Search - Département Méthodes quantitatives en santé publique Access content directly

Filter your results

39 Results
keyword_s : Multiple sclerosis
Image document

Multiple sclerosis: effect of beta interferon treatment on survival

Elaine Kingwell , Emmanuelle Leray , Feng Zhu , John Petkau , Gilles Edan , et al.
Brain - A Journal of Neurology , 2019, 142 (5), pp.1324-1333. ⟨10.1093/brain/awz055⟩
Journal articles hal-02088095v1

Criteria improving multiple sclerosis diagnosis at the first MRI

Nathalie Caucheteux , Adil Maarouf , Margaux Genevray , Emmanuelle Leray , Romain Deschamps , et al.
Journal of Neurology, 2015, 262 (4), pp.979 - 987. ⟨10.1007/s00415-015-7668-9⟩
Journal articles hal-01378308v1
Image document

Use of healthcare services by patients with multiple sclerosis in France over 2010-2015: a nationwide population-based study using health administrative data

Jonathan Roux , Alice Guilleux , Mathilde Lefort , Emmanuelle Leray
Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2019, 5 (4), pp.2055217319896090. ⟨10.1177/2055217319896090⟩
Journal articles hal-02444012v1
Image document

Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses

Maxime Jeanjean , Marie-Abele Bind , Jonathan Roux , Jean-Claude Ongagna , Jérôme de Sèze , et al.
Environmental Research, 2018, 163, pp.43-52. ⟨10.1016/j.envres.2018.01.040⟩
Journal articles hal-01740486v1

Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.

Emmanuelle Leray , M. Coustans , Emmanuelle Le Page , J. Yaouanq , Joel Oger , et al.
Multiple Sclerosis Journal, 2013, 19 (4), pp.458-65. ⟨10.1177/1352458512456613⟩
Journal articles hal-00878705v1
Image document

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

David-Axel Laplaud , Romain Casey , Laetitia Barbin , Marc Debouverie , Jerome de Sèze , et al.
Neurology, 2019, 93 (7), pp.e635-e646. ⟨10.1212/WNL.0000000000007938⟩
Journal articles inserm-02289153v1

Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

C. Lebrun , S. Vukusic , V. Abadie , C. Achour , F. Ader , et al.
Revue Neurologique, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Journal articles hal-02546158v1
Image document

Disability Progression in Multiple Sclerosis Patients using Early First-line Treatments

Mathilde Lefort , Sandra Vukusic , Romain Casey , Gilles Edan , Emmanuelle Leray
European Journal of Neurology, 2022, 29 (9), pp.2761-2771. ⟨10.1111/ene.15422⟩
Journal articles hal-03690316v1

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: A 5-year prospective study

Emmanuelle Le Page , Emmanuelle Leray , Gilles Edan
Multiple Sclerosis Journal, 2011, 17 (7), pp.867-875. ⟨10.1177/1352458511398371⟩
Journal articles hal-02437110v1
Image document

Parcours de soins des patients atteints de sclérose en plaques à partir des données médico-administratives en France

Jonathan Roux
Médecine humaine et pathologie. Université de Rennes, 2018. Français. ⟨NNT : 2018REN1B042⟩
Theses tel-02379451v1

Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system

Camille Sabathé , Romain Casey , Sandra Vukusic , Emmanuelle Leray , Guillaume Mathey , et al.
Multiple Sclerosis Journal, 2023, 29 (2), pp.236-247. ⟨10.1177/13524585221139156⟩
Journal articles hal-04086418v1
Image document

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

M. Lefort , S. Sharmin , J. Andersen , S. Vukusic , R. Casey , et al.
BMC Medical Research Methodology, 2022, 22 (1), pp.155. ⟨10.1186/s12874-022-01623-8⟩
Journal articles hal-03690493v1
Image document

Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis

Kevin Ahrweiller , Chloé Rousseau , Emmanuelle Le Page , Emma Bajeux , Emmanuelle Leray , et al.
Multiple Sclerosis Journal, 2020, 26 (8), pp.924-935. ⟨10.1177/1352458519848090⟩
Journal articles hal-02150346v1

Multichannel sequence analysis: An innovative method to study patterns of care pathways. Application to multiple sclerosis based on French Health Insurance data

Jonathan Roux , Olivier Grimaud , Emmanuelle Leray
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2018, 66, pp.S430-S431. ⟨10.1016/j.respe.2018.05.534⟩
Journal articles hal-02921552v1
Image document

High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice

Laura Couloume , Laetitia Barbin , Emmanuelle Leray , Sandrine Wiertlewski , Emmanuelle Le Page , et al.
Multiple Sclerosis Journal, 2020, 26 (14), pp.1898-1906. ⟨10.1177/1352458519894713⟩
Journal articles hal-02436685v1
Image document

Long‐term effect of first‐line injectable multiple sclerosis treatments: input of a time‐dependent propensity score

Mathilde Lefort , Yohann Foucher , Rémi Lenain , Sandra Vukusic , Gilles Edan , et al.
Pharmacoepidemiology and Drug Safety, 2020, 29 (12), pp.1680-1688. ⟨10.1002/pds.5154⟩
Journal articles hal-02979802v1
Image document

Assessing environmental epidemiology questions in practice with a causal inference pipeline: An investigation of the air pollution-multiple sclerosis relapses relationship

Alice J. Sommer , Emmanuelle Leray , Young Lee , Marie-Abele C. Bind
Statistics in Medicine, 2021, 40 (6), pp.1321-1335. ⟨10.1002/sim.8843⟩
Journal articles hal-03101469v1
Image document

Use of state sequence analysis for care pathway analysis: The example of multiple sclerosis

Jonathan Roux , Olivier Grimaud , Emmanuelle Leray
Statistical Methods in Medical Research, 2019, 28 (6), pp.1651-1663. ⟨10.1177/0962280218772068⟩
Journal articles hal-01798652v1

Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study

Soline Leblanc , Jonathan Roux , Hélène Tillaut , Emmanuelle Le Page , Emmanuelle Leray
Revue Neurologique, 2021, 177 (10), pp.1250-1261. ⟨10.1016/j.neurol.2021.04.006⟩
Journal articles hal-03312766v1

Care-seeking of patients with multiple sclerosis over 2010-2015 in France - a nationwide study using health administrative data

Jonathan Roux , A. Guilleux , Olivier Grimaud , Emmanuelle Leray
Multiple Sclerosis Journal, 2018, 24, pp.550-551
Journal articles hal-01935074v1
Image document

Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, Canada

Jonathan Roux , Elaine Kingwell , Feng Zhu , Helen Tremlett , Emmanuelle Leray
Multiple Sclerosis Journal, 2022, 28 (2), pp.309-322. ⟨10.1177/13524585211016726⟩
Journal articles hal-03246670v1
Image document

Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France

Soline Leblanc , Mathilde Lefort , Emmanuelle Le Page , Laure Michel , Emmanuelle Leray
Expert Review of Neurotherapeutics, 2022, 22 (5), pp.411-418. ⟨10.1080/14737175.2022.2061950⟩
Journal articles hal-03629848v1
Image document

Determinants of Therapeutic Lag in Multiple Sclerosis

Izanne Roos , Emmanuelle Leray , Federico Frascoli , Romain Casey , J William L Brown , et al.
Multiple Sclerosis Journal, 2021, 27 (12), pp.1838-1851. ⟨10.1177/1352458520981300⟩
Journal articles hal-03223056v1

Identification of Therapeutic Lag in Multiple Sclerosis

Izanne Roos , Emmanuelle Leray , Federico Frascoli , Romain Casey , Dana Horakova , et al.
Neurology, 2020, 94 (15)
Journal articles hal-02929403v1
Image document

Assessing the Risk of Relapse Requiring Corticosteroids After In Vitro Fertilization in Women With Multiple Sclerosis

Marie Mainguy , Hélène Tillaut , Adeline Degremont , Emmanuelle Le Page , Christelle Mainguy , et al.
Neurology, 2022, pp.10.1212/WNL.0000000000201027. ⟨10.1212/WNL.0000000000201027⟩
Journal articles hal-03751891v1
Image document

Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

C Walton , Rachel King , Lindsay Rechtman , Wendy Kaye , Emmanuelle Leray , et al.
Multiple Sclerosis Journal, 2020, 26 (14), pp.1816-1821. ⟨10.1177/1352458520970841⟩
Journal articles hal-03038709v1

A new treatment era in multiple sclerosis: Clinical applications of new concepts

Gilles Edan , Emmanuelle Leray
Journal of the Neurological Sciences, 2011, 306 (1-2), pp.170-172. ⟨10.1016/j.jns.2010.09.018⟩
Journal articles istex hal-02437067v1

Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies

Hélène Tillaut , Adeline Degrémont , Sandrine Kerbrat , Jonathan Roux , Emmanuelle Le Page , et al.
Multiple Sclerosis Journal, 2022, 28 (5), pp.778-789. ⟨10.1177/13524585211035376⟩
Journal articles hal-03819581v1

Geographical variations in access to expert centers for multiple sclerosis in France

Emmanuelle Leray , F. Mamadou , A. Guilleux , Jonathan Roux , Olivier Grimaud
European Journal of Public Health, 2019, 29 (Supplement_4), pp.80-80. ⟨10.1093/eurpub/ckz185.205⟩
Journal articles hal-02470788v1
Image document

COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients

Soizic Leguy , Mathilde Lefort , Lucile Lescot , Audrey Michaud , Sandra Vukusic , et al.
Journal of Neurology, 2022, 269 (269), pp.5571-5581. ⟨10.1007/s00415-022-11215-7⟩
Journal articles hal-03704177v1